Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21097355 | 1.00 | MAPK1 (0.34) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL21162375 | 0.79 | PPM1B (0.39) | MEN1KMT2A | |
| SCHEMBL295484 | 0.79 | MAPK1 (0.43) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL18346713 | 0.79 | MAPK1 (0.43) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL19134374 | 0.79 | MAPK1 (0.43) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL18828485 | 0.79 | MAPK1 (0.43) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL910314 | 0.79 | MAPK1 (0.36) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL30718013 | 0.79 | MAPK1 (0.36) | MAPK1CHRM2CHRM1CHRM3HRH3 | |
| SCHEMBL15058695 | 0.79 | BTK (0.38) | MAPK1CHRM2CHRM1CHRM3MEN1 | |
| SCHEMBL12521652 | 0.79 | HRH3 (0.39) | MAPK1CHRM2CHRM1CHRM3HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10343974-B1 | Cyclohexanol ethers as mediterranean fruit fly attractants | The United States of America, as represented by The Secretary of America (US) | 2019-07-09 | — | — | US | claimed |
| US-10343974-B1 | Cyclohexanol ethers as mediterranean fruit fly attractants | The United States of America, as represented by The Secretary of America (US) | 2019-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343974-B1 | Cyclohexanol ethers as mediterranean fruit fly attractants | C3AR1, CERS2, C1S | MAPK1 2765/4885CHRM2 21/4885CHRM1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.